These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35873285)

  • 1. Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease.
    Khan F; Allehebi Z; Shabi Y; Davis I; LeBlanc J; Lindsay R; Hatchette T
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac272. PubMed ID: 35873285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
    Davis IRC; McNeil SA; Allen W; MacKinnon-Cameron D; Lindsay LR; Bernat K; Dibernardo A; LeBlanc JJ; Hatchette TF
    J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32321781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.
    Pegalajar-Jurado A; Schriefer ME; Welch RJ; Couturier MR; MacKenzie T; Clark RJ; Ashton LV; Delorey MJ; Molins CR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin.
    Sabin AP; Scholze BP; Lovrich SD; Callister SM
    Diagn Microbiol Infect Dis; 2023 Jan; 105(1):115837. PubMed ID: 36370542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context.
    Can Commun Dis Rep; 2020 May; 46(5):125-131. PubMed ID: 32558809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays.
    Sfeir MM; Meece JK; Theel ES; Granger D; Fritsche TR; Steere AC; Branda JA
    J Clin Microbiol; 2022 May; 60(5):e0252821. PubMed ID: 35418241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the rapid Quidel Sofia Lyme fluorescent immunoassay as a first-tier test in a modified 2-tier testing algorithm for Lyme disease: A comparison with the Zeus ELISA Borrelia VlsE1/pepC10 lgG/IgM assay followed by the Zeus monovalent IgM/IgG confirmatory assay.
    Lee-Lewandrowski E; Turbett S; Branda JA; Lewandrowski K
    Am J Clin Pathol; 2023 Dec; 160(6):599-602. PubMed ID: 37549102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.
    Landry ML; Hassan S; Rottmann BG; Pesak SJ; Ordazzo M; Skrzyniarz M; Deponte S; Peaper DR
    J Clin Microbiol; 2024 May; 62(5):e0013924. PubMed ID: 38597655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.
    Branda JA; Strle K; Nigrovic LE; Lantos PM; Lepore TJ; Damle NS; Ferraro MJ; Steere AC
    Clin Infect Dis; 2017 Apr; 64(8):1074-1080. PubMed ID: 28329259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.
    Lipsett SC; Branda JA; Nigrovic LE
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31413078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
    Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
    J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A focused review on Lyme disease diagnostic testing: An update on serology algorithms, current ordering practices, and practical considerations for laboratory implementation of a new testing algorithm.
    Kenyon SM; Chan SL
    Clin Biochem; 2023 Jul; 117():4-9. PubMed ID: 34875253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
    Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
    Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples.
    Molins CR; Delorey MJ; Sexton C; Schriefer ME
    J Clin Microbiol; 2016 Nov; 54(11):2726-2734. PubMed ID: 27558183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Lyme Serological Testing Platforms with a Panel of Clinically Characterized Samples from Various Stages of Lyme Disease.
    Pratt GW; Platt M; Velez A; Rao LV
    J Appl Lab Med; 2022 Oct; 7(6):1445-1449. PubMed ID: 35716134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the Lyme Disease Serodiagnostic Algorithm: the Momentum Gathers.
    Marques AR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29898997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.
    Lipsett SC; Branda JA; McAdam AJ; Vernacchio L; Gordon CD; Gordon CR; Nigrovic LE
    Clin Infect Dis; 2016 Oct; 63(7):922-8. PubMed ID: 27358358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.
    Lahey LJ; Panas MW; Mao R; Delanoy M; Flanagan JJ; Binder SR; Rebman AW; Montoya JG; Soloski MJ; Steere AC; Dattwyler RJ; Arnaboldi PM; Aucott JN; Robinson WH
    J Clin Microbiol; 2015 Dec; 53(12):3834-41. PubMed ID: 26447113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe.
    Branda JA; Strle F; Strle K; Sikand N; Ferraro MJ; Steere AC
    Clin Infect Dis; 2013 Aug; 57(3):333-40. PubMed ID: 23592827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
    Wormser GP; Molins CR; Levin A; Lipsett SC; Nigrovic LE; Schriefer ME; Branda JA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):217-219. PubMed ID: 29550060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.